Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 14,900 shares at $171.59 ($2.6M) on 2021-06-01, disclosed to the SEC on 2021-06-03.
Open-market sale of $2.6M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $171.59 | 2,500 | $429K | 16.5% |
| 2 | $172.85 | 800 | $138K | 5.3% |
| 3 | $173.94 | 1,000 | $174K | 6.7% |
| 4 | $174.93 | 1,994 | $349K | 13.4% |
| 5 | $174.93 | 1,994 | $349K | 13.4% |
| 6 | $175.77 | 2,906 |
| $511K |
| 19.6% |
| 7 | $175.77 | 2,906 | $511K | 19.6% |
| 8 | $178.07 | 300 | $53K | 2.1% |
| 9 | $179.21 | 200 | $36K | 1.4% |
| 10 | $180.02 | 300 | $54K | 2.1% |
| Total | $174.74 avg | 14,900 | $2.6M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |